Ignite Creation Date:
2024-05-06 @ 12:51 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03863990
Status:
COMPLETED
Last Update Posted:
2021-05-04
First Post:
2019-02-19
Brief Title:
Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
Survival and Prognostic Factors in Pulmonary Arterial Hypertension A Multicenter Observational Registry START
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
START
Brief Summary:
In this study researchers want to learn more about Pulmonary Arterial Hypertension a type of high blood pressure in the lungs related to the narrowing of the small blood vessels in the lungs group 1 according to WHO classification Goal of the study is to describe the signs and risk factors of the illness at study start and the chances of survival
Detailed Description:
The primary objective of the study is to describe baseline clinical characteristics and overall survival in a cohort of patients with pulmonary arterial hypertension PAH of WHO functional class I in Argentina
Secondary objectives are to study the discriminatory ability of the risk assessment tool presented in the European Society of Cardiology and European Respiratory Society ESCERS 2015 guidelines and to explore the potential prognostic advantage of a low-risk profile at follow-up as treatment goal
Secondary objectives are to study the discriminatory ability of the risk assessment tool presented in the European Society of Cardiology and European Respiratory Society ESCERS 2015 guidelines and to explore the potential prognostic advantage of a low-risk profile at follow-up as treatment goal
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None